Ex-Insys Directors Agree to $175 Million Opioid-Sale Accord (1)

Some former directors of Insys Therapeutics Inc. have agreed to a potential $175 million settlement of claims they failed to properly oversee salespeople who illegally marketed the company’s opioid painkiller, which led to the jailing of top executives.

The accord — which will be partially paid by directors themselves — resolves allegations that four board members turned a blind eye to bribes paid to doctors who prescribed the company’s fentanyl-based spray, Subsys, to rack up massive profits.

Former Insys Chairman and Chief Executive Officer John Kapoor is not party to the settlement. Kapoor was convicted of racketeering tied to ...